153 related articles for article (PubMed ID: 38321606)
1. The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in breast cancer patients.
Yamaguchi H; Fukumitsu N; Numajiri H; Ogino H; Okimoto T; Ogino T; Suzuki M; Murayama S
J Radiat Res; 2024 Mar; 65(2):231-237. PubMed ID: 38321606
[TBL] [Abstract][Full Text] [Related]
2. The Japanese nationwide cohort data of proton beam therapy for liver oligometastasis in esophagogastric cancer patients.
Yamaguchi H; Fukumitsu N; Numajiri H; Ogino H; Katoh N; Okimoto T; Suzuki M; Sakurai H
J Radiat Res; 2023 Nov; 64(6):926-932. PubMed ID: 37697668
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of proton beam therapy for liver oligometastatic recurrence in patients with postoperative esophagus cancer.
Yamaguchi H; Kato T; Honda M; Hamada K; Seto I; Tominaga T; Takagawa Y; Takayama K; Suzuki M; Kikuchi Y; Teranishi Y; Murakami M
J Radiat Res; 2023 May; 64(3):582-589. PubMed ID: 36913708
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes and factors involved in the local control of proton beam therapy for oligometastatic liver tumors in patients with colorectal cancer.
Yamaguchi H; Kato T; Honda M; Hamada K; Todate Y; Ishikawa Y; Seto I; Tominaga T; Machida M; Takagawa Y; Takayama K; Suzuki M; Kikuchi Y; Teranishi Y; Murakami M; Konno S
Strahlenther Onkol; 2023 Mar; 199(3):304-312. PubMed ID: 36446925
[TBL] [Abstract][Full Text] [Related]
5. Proton Beam Therapy for Hepatocellular Carcinoma: Multicenter Prospective Registry Study in Japan.
Mizumoto M; Ogino H; Okumura T; Terashima K; Murakami M; Ogino T; Tamamura H; Akimoto T; Waki T; Katoh N; Araya M; Onoe T; Takagi M; Iwata H; Numajiri H; Okimoto T; Uchinami Y; Maruo K; Shibuya K; Sakurai H
Int J Radiat Oncol Biol Phys; 2024 Mar; 118(3):725-733. PubMed ID: 37778422
[TBL] [Abstract][Full Text] [Related]
6. Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis.
Thorpe CS; Niska JR; Girardo ME; Kosiorek HE; McGee LA; Hartsell WF; Larson GL; Tsai HK; Rossi CJ; Rosen LR; Vargas CE
Breast J; 2019 Nov; 25(6):1160-1170. PubMed ID: 31338974
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes and toxicity of proton beam therapy for advanced cholangiocarcinoma.
Makita C; Nakamura T; Takada A; Takayama K; Suzuki M; Ishikawa Y; Azami Y; Kato T; Tsukiyama I; Kikuchi Y; Hareyama M; Murakami M; Fuwa N; Hata M; Inoue T
Radiat Oncol; 2014 Jan; 9():26. PubMed ID: 24422711
[TBL] [Abstract][Full Text] [Related]
8. Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-Small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.
Ohnishi K; Nakamura N; Harada H; Tokumaru S; Wada H; Arimura T; Iwata H; Sato Y; Sekino Y; Tamamura H; Mizoe JE; Ogino T; Ishikawa H; Kikuchi Y; Okimoto T; Murayama S; Akimoto T; Sakurai H
Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):82-89. PubMed ID: 31580927
[TBL] [Abstract][Full Text] [Related]
9. Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.
Iizumi T; Okumura T; Sekino Y; Takahashi H; Tsai YL; Takizawa D; Ishida T; Hiroshima Y; Nakamura M; Shimizu S; Saito T; Numajiri H; Mizumoto M; Nakai K; Sakurai H
J Radiat Res; 2021 Jul; 62(4):682-687. PubMed ID: 34036362
[TBL] [Abstract][Full Text] [Related]
10. A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases.
Kim K; Yu JI; Park HC; Yoo GS; Lim DH; Noh JM; Jeong WK
Radiother Oncol; 2022 Nov; 176():9-16. PubMed ID: 36113779
[TBL] [Abstract][Full Text] [Related]
11. Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group.
Parzen JS; Hartsell W; Chang J; Apisarnthanarax S; Molitoris J; Durci M; Tsai H; Urbanic J; Ashman J; Vargas C; Stevens C; Kabolizadeh P
Radiat Oncol; 2020 Nov; 15(1):255. PubMed ID: 33148296
[TBL] [Abstract][Full Text] [Related]
12. Proton Beam Therapy for Lung Oligometastatic Recurrence in Patients With Esophageal Cancer.
Yamaguchi H; Kato T; Honda M; Hamada K; Ishikawa Y; Seto I; Takagawa Y; Suzuki M; Kikuchi Y; Murakami M
Cureus; 2023 Dec; 15(12):e50343. PubMed ID: 38205500
[TBL] [Abstract][Full Text] [Related]
13. Chest wall toxicity after hypofractionated proton beam therapy for liver malignancies.
Yeung R; Bowen SR; Chapman TR; MacLennan GT; Apisarnthanarax S
Pract Radiat Oncol; 2018; 8(4):287-293. PubMed ID: 29452863
[TBL] [Abstract][Full Text] [Related]
14. Follow-up study of liver metastasis from breast cancer treated by proton beam therapy.
Fukumitsu N; Okumura T; Numajiri H; Takizawa D; Ohnishi K; Mizumoto M; Aihara T; Ishikawa H; Tsuboi K; Sakurai H
Mol Clin Oncol; 2017 Jul; 7(1):56-60. PubMed ID: 28685076
[TBL] [Abstract][Full Text] [Related]
15. The role of proton beam therapy in central neurocytoma: A single-institution experience.
Kang KH; Schapira E; Niemierko A; Martinez-Lage M; Bussière MR; Yock TI; Loeffler JS; Butler WE; Carter BS; Shih HA
Pract Radiat Oncol; 2018; 8(5):e305-e311. PubMed ID: 29706302
[TBL] [Abstract][Full Text] [Related]
16. The effectiveness of proton beam therapy for liver metastatic recurrence in gastric cancer patients.
Yamaguchi H; Honda M; Hamada K; Kobayashi H; Todate Y; Seto I; Takayama K; Suzuki M; Wada H; Kikuchi Y; Murakami M
Jpn J Clin Oncol; 2020 Aug; 50(8):903-908. PubMed ID: 32363379
[TBL] [Abstract][Full Text] [Related]
17. Proton beam therapy for liver metastases from gastric cancer.
Fukumitsu N; Okumura T; Takizawa D; Numajiri H; Ohnishi K; Mizumoto M; Aihara T; Ishikawa H; Tsuboi K; Sakurai H
J Radiat Res; 2017 May; 58(3):357-362. PubMed ID: 27974509
[TBL] [Abstract][Full Text] [Related]
18. Acute toxicities after proton beam therapy following breast-conserving surgery for breast cancer: Multi-institutional prospective PCG registry analysis.
Thorpe CS; Niska JR; Anderson JD; Girardo ME; McGee LA; Hartsell WF; Larson GL; Tsai HK; Rossi CJ; Rosen LR; Vargas CE
Breast J; 2020 Sep; 26(9):1760-1764. PubMed ID: 32297453
[TBL] [Abstract][Full Text] [Related]
19. Prospective study of proton-beam radiation therapy for limited-stage small cell lung cancer.
Rwigema JM; Verma V; Lin L; Berman AT; Levin WP; Evans TL; Aggarwal C; Rengan R; Langer C; Cohen RB; Simone CB
Cancer; 2017 Nov; 123(21):4244-4251. PubMed ID: 28678434
[TBL] [Abstract][Full Text] [Related]
20. Proton Therapy for Primary Renal Cell Carcinoma: The First Nationwide Retrospective Study in Japan.
Fukumitsu N; Ishikawa H; Arimura T; Wada H; Okimoto T; Sato Y; Iwata H; Shimizu S; Sakurai H
In Vivo; 2020; 34(5):2883-2889. PubMed ID: 32871828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
